scispace - formally typeset
A

Andrea L. Richardson

Researcher at Johns Hopkins University

Publications -  186
Citations -  61984

Andrea L. Richardson is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 84, co-authored 171 publications receiving 53291 citations. Previous affiliations of Andrea L. Richardson include Brigham and Women's Hospital & University of Queensland.

Papers
More filters
Journal ArticleDOI

Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

Catherine M. Phelan, +443 more
- 01 May 2017 - 
TL;DR: Integrated analyses of genes and regulatory biofeatures at each locus predicted candidate susceptibility genes, including OBFC1, a new candidate susceptibility gene for low-grade and borderline serous EOC.
Journal ArticleDOI

Phyllodes tumours of the breast: a consensus review

Benjamin Y. Tan, +24 more
- 01 Jan 2016 - 
TL;DR: A review of the current understanding of phyllodes tumours and clinical behaviour is presented in this article. But, there is no consensus on the definition of an appropriate surgical margin to ensure completeness of excision and reduction of recurrence risk.
Journal ArticleDOI

Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer

Sabina Signoretti, +8 more
- 01 Sep 2002 - 
TL;DR: Skp2 has oncogenic potential in breast epithelial cells and is overexpressed in a subset of breast carcinomas (ER- and Her-2 negative) for which Skp2 inhibitors may represent a valid therapeutic option.
Journal Article

Molecular Markers in Ductal Carcinoma in Situ of the Breast

Dale Porter, +13 more
- 01 Mar 2003 - 
TL;DR: It is found that that the most dramatic transcriptome change occurs at the normal to DCIS transition, while there is no clear universal "in situ" or "invasive" tumor molecular signature.
Journal ArticleDOI

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer.

Roger L. Milne, +512 more
- 23 Oct 2017 - 
TL;DR: A genome-wide association study (GWAS) of predominantly estrogen receptor (ER)-positive disease and BRCA1 mutation carrier GWAS observed consistent associations with ER-negative disease for 105 susceptibility variants identified by other studies, which explain approximately 16% of the familial risk of this breast cancer subtype.